Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Fall 2021’s Awards, Appointments & Announcements in Rheumatology

Gretchen Henkel  |  Issue: October 2021  |  October 13, 2021

Sebastian E. Sattui, MD, MS, Joins UPMC as Director of Vasculitis Center

Sebastian E. Sattui, MD, MSOn July 1, Sebastian E. Sattui, MD, MS, assumed an appointment as director of the University of Pittsburgh Medical Center (UPMC) Vasculitis Center. Between his rheuma­tology and vasculitis fellowships at Weill Cornell Medical College/Hospital for Special Surgery, New York, Dr. Sattui, who is also now assistant professor of medicine at the University of Pittsburgh School of Medicine, has spent four years preparing for this role.

His initial tasks at UPMC involve establishing collaborations with colleagues in other specialties to provide the multispecialty care required to secure good outcomes for patients with vasculitis and polymyalgia rheumatica (PMR). He’s also intent upon helping to streamline patients’ interface with the medical center. “It’s already hard enough [for patients to have] a complex chronic condition, even more so new patients, so we are trying to help them navigate the medical system and make the process easier and more efficient,” he says. “Our goal is to provide timely and multidisciplinary care to all patients.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Sattui’s recent clinical research has focused on evaluating mitochondrial DNA as a measure of disease activity in vasculitis, and he will continue collaborations in that vein following wrap-up of a pilot study with colleagues at the Hospital for Special Surgery (HSS), New York, including Robert S. Spiera, MD, director of the HSS Scleroderma, Vasculitis and Myositis Center, as well as Lindsay S. Lally, MD, assistant professor of medicine at Weill Cornell Medical College.

Dr. Sattui is also focusing on research involving the compounding factors of frailty in patients with vasculitis and PMR to work toward improving the quality of life of patients living with these conditions. The overlap between frailty and these conditions will continue to be relevant, he believes, because of the age of the population affected. With his new position, there will be abundant opportunity to elucidate the effects of frailty.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

He has also participated in an ACR-funded international survey of the health behaviors of people with rheumatic disease during the pandemic, which found the majority of these patients had maintained their therapy and followed public health advice to mitigate the risks of COVID-19 exposure.

Carol M. Ziminski, MD, Presented with Award for Excellence in Teaching

Carol M. Ziminski, MDAn academic rheumatologist renowned and often celebrated throughout her nearly 40-year career for her commitment to teaching, Carol M. Ziminski, MD, rates her recent award, the Professors’ Award for Excellence in Teaching to a member of the part-time faculty, high on her list of proud achievements. “I was surprised and delighted when I got the news,” she said, upon learning of the award, which was announced at the Johns Hopkins School of Medicine, Baltimore, convocation in late May.

Also high on her list of proud career achievements is her time as the Department of Medicine’s first woman assistant chief of service, a position she held during the 1981–82 academic year. She was just past her Osler internship and residency years when the late Victor McKusick, MD, appointed her to the post. Still a rheumatology fellow at the time, Dr. Ziminski consulted her valued mentor, the late Mary Betty Stevens, MD, when making her decision to accept the appointment.

Dr. Stevens, who as the first woman director of the division of rheumatology was also a trailblazer, gave her a full endorsement. Even after she was hired as a junior faculty member, Dr. Ziminski still made it a point to round with Dr. Stevens. The latter’s ability to interact with and listen to patients became one of the through-lines in Dr. Ziminski’s own teaching methods.

The late Philip A. Tumulty, MD, was another role model, who emphasized in his book, The Effective Clinician, and his own teaching the primary importance of history taking to determine accurate diagnoses. As a core faculty member of the Vivian Thomas College’s Advisory Program, Dr. Ziminski continues to draw on the principles of listening to and observing the patient to make clinical determinations critical to diagnosis and passes on those principles to her advisees.

She says she has also benefited from the example of Antony Rosen, MD, the current director of the Division of Rheumatology, who has championed the pursuit of excellence in the division.

Dr. Ziminski was previously honored with a Hopkins Hero award upon the 125th anniversary of the institution in 2018.

She remains passionate about teaching and about rheumatology, a field which she believes is growing. This is due, in part, she notes, to the aging of the population and also to the explosion of interest and knowledge about immunology and the important pathways to disease. “The field is broad; it’s challenging and rewarding. You can make an enormous difference in people’s lives.”

Page: 1 2 3 4 | Single Page
Share: 

Filed under:Awards Tagged with:Dr. Carol ZiminskiDr. Gordon HutchinsonDr. Jason SpringerDr. Jeffrey SiegelDr. Sebastian Sattui

Related Articles

    Research Offers Insight into Diagnosis, Treatment of Small-Vessel Vasculitis

    March 20, 2017

    WASHINGTON, D.C.—Experts speaking at the 2016 ACR/ARHP Annual Meeting session, Update on Small-Vessel Vasculitis, offered insight into the latest approaches to the diagnosis and treatment of diseases involving the inflammation of blood vessels. “Vasculitis is an immune-mediated process. White blood cells invade the vessel wall, causing inflammation throughout the vessel wall,” said Jason M. Springer,…

    Former Senator Tim Hutchinson Urges ACR Members to Advocate for Rheumatology on Local, State and Federal Levels

    January 19, 2017

    WASHINGTON, D.C.—“Regardless of where we are on the political spectrum, we have to get engaged,” said Sen. Tim Hutchinson, senior director, Greenberg Traurig LLP, Washington, D.C., speaking at the 2016 ACR/ARHP Annual Meeting. As a former U.S. senator from Arkansas, Sen. Hutchinson talked about the importance of members in such organizations as the ACR to…

    ilusmedical / shutterstock.com

    The State of Clinical Research in Vasculitis: 2021

    January 19, 2021

    It is an exciting time in the world of vasculitis research. More clinical studies and trials are being conducted now than at any time in history. In the past ten years, four drugs have been approved by the U.S. Food & Drug Administration (FDA) and other regulatory agencies specifically for the treatment of vasculitis: Rituximab…

    Advocacy in the Social Media Era

    October 19, 2017

    Advocacy efforts in the medical profession are evolving as technology evolves. The rise of social media, in particular, has brought about great change in the way organizations, such as the ACR, interact with Congress. At the 2017 ACR/ARHP Annual Meeting, Nov. 3–8 in San Diego, former Sen. Tim Hutchinson (R-Ark.) will discuss how to continue…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences